Biopharmaceutical companies are under a great deal of financial pressure these days, and many are tinkering with long established business models. There can be no doubt that the industry is in flux as a result of pricing pressures from insurance companies, changing patent regulations and expirations, healthcare reform, and an increased focus on proving significant clinical benefits. Sadly, this is all taking place at a time when the largest biopharma companies have developed a black eye as a result of a seemingly endless series of ethical transgressions, including off-label drug promotions, hidden clinical trial outcomes, bribes and kickbacks for writing prescriptions, manufacturing breakdowns, and lawsuits tied to numerous medicines pulled off the market.
Hey, check out all the research scientist jobs. Post your resume today!
